BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31611980)

  • 1. STMN1 accumulation is associated with dysplastic and neoplastic lesions in patients with ulcerative colitis.
    Osone K; Yokobori T; Katayama C; Takahashi R; Kato R; Tatsuski H; Takada T; Yajima R; Motegi Y; Ogawa H; Fujii T; Ojima H; Nakamura J; Yao T; Shirabe K; Kuwano H
    Oncol Lett; 2019 Nov; 18(5):4712-4718. PubMed ID: 31611980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 Expression as a Diagnostic Biomarker in Ulcerative Colitis-Associated Cancer.
    Kobayashi K; Tomita H; Shimizu M; Tanaka T; Suzui N; Miyazaki T; Hara A
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28621756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
    Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
    J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer.
    Chen R; Pan S; Lai K; Lai LA; Crispin DA; Bronner MP; Brentnall TA
    World J Gastroenterol; 2014 Dec; 20(45):17037-48. PubMed ID: 25493016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solute carrier family 12 member 2 as a proteomic and histological biomarker of dysplasia and neoplasia in ulcerative colitis.
    Merli AM; Vieujean S; Massot C; Blétard N; Quesada Calvo F; Baiwir D; Mazzucchelli G; Servais L; Wéra O; Oury C; de Leval L; Sempoux C; Manzini R; Bluemel S; Scharl M; Rogler G; De Pauw E; Coimbra Marques C; Colard A; Vijverman A; Delvenne P; Louis E; Meuwis MA
    J Crohns Colitis; 2020 Sep; ():. PubMed ID: 32920643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
    Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PHLDA1 expression in ulcerative colitis: A potential role in the management of dysplasia.
    Orita F; Ishikawa T; Ishiguro M; Okazaki S; Kikuchi A; Yamauchi S; Matsuyama T; Tokunaga M; Uetake H; Kinugasa Y
    Mol Clin Oncol; 2021 Sep; 15(3):192. PubMed ID: 34349991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pattern of CD44 and matrix metalloproteinase 9 expression is a useful predictor of ulcerative colitis-associated dysplasia and neoplasia.
    AbdElazeem MA; El-Sayed M
    Ann Diagn Pathol; 2015 Dec; 19(6):369-74. PubMed ID: 26420348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
    Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
    Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-L1 upregulation is associated with activation of the DNA double-strand break repair pathway in patients with colitic cancer.
    Ozawa N; Yokobori T; Osone K; Katayama C; Suga K; Komine C; Shibasaki Y; Shiraishi T; Okada T; Kato R; Ogawa H; Sano A; Sakai M; Sohda M; Ojima H; Miyazaki T; Motegi Y; Ide M; Yao T; Kuwano H; Shirabe K; Saeki H
    Sci Rep; 2021 Jun; 11(1):13077. PubMed ID: 34158547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profiling of ulcerative colitis-associated neoplastic progression.
    Colliver DW; Crawford NP; Eichenberger MR; Zacharius W; Petras RE; Stromberg AJ; Galandiuk S
    Exp Mol Pathol; 2006 Feb; 80(1):1-10. PubMed ID: 16277983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohistochemical distribution of p53 and Ki-67 in 2 cases of colorectal carcinoma occurring in ulcerative colitis].
    Maruyama K; Saigusa N; Baba S; Kino I
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():145-8. PubMed ID: 7611778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The miR-200 family is increased in dysplastic lesions in ulcerative colitis patients.
    Lewis A; Felice C; Kumagai T; Lai C; Singh K; Jeffery RR; Feakins R; Giannoulatou E; Armuzzi A; Jawad N; Lindsay JO; Silver A
    PLoS One; 2017; 12(3):e0173664. PubMed ID: 28288169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of segmental colorectal lavage cytology during surveillance colonoscopy for detecting dysplastic and cancer cells in patients with ulcerative colitis.
    Torii Y; Sano D; Ikeuchi H; Hida N; Hirota S
    Int J Clin Exp Pathol; 2020; 13(8):2035-2040. PubMed ID: 32922598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pattern of cell proliferation in neoplastic and nonneoplastic lesions of ulcerative colitis.
    Noffsinger AE; Miller MA; Cusi MV; Fenoglio-Preiser CM
    Cancer; 1996 Dec; 78(11):2307-12. PubMed ID: 8940999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating neoplastic progression of ulcerative colitis with label-free comparative proteomics.
    May D; Pan S; Crispin DA; Lai K; Bronner MP; Hogan J; Hockenbery DM; McIntosh M; Brentnall TA; Chen R
    J Proteome Res; 2011 Jan; 10(1):200-9. PubMed ID: 20828217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA Class I Expression Is Associated with DNA Damage and Immune Cell Infiltration into Dysplastic and Neoplastic Lesions in Ulcerative Colitis.
    Okami H; Ozawa N; Sohda M; Yokobori T; Osone K; Erkhem-Ochir B; Dorjkhorloo G; Shiraishi T; Okada T; Sano A; Sakai M; Miyazaki T; Ogawa H; Yao T; Oike T; Sato H; Shirabe K; Shibata A; Saeki H
    Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 mutation in patients with ulcerative colitis in rectal biopsy.
    Kim HJ; Chang SK
    Korean J Intern Med; 1998 Jul; 13(2):110-6. PubMed ID: 9735666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free.
    Chen R; Rabinovitch PS; Crispin DA; Emond MJ; Koprowicz KM; Bronner MP; Brentnall TA
    Am J Pathol; 2003 Feb; 162(2):665-72. PubMed ID: 12547724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
    Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
    Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.